BROOKLYN Stock Today

It looks like this equity (NTN) cannot be resolved or is no longer available, but we have found another equity that may match the characteristics of what you are looking for. Please check BTX Brooklyn Immunotherapeutics to make sure you are using current equity.
BROOKLYN IMMUNOTHERAPEUTICS INC cannot be verified against its exchange. Apparently, BROOKLYN IMMUNOTHERAPEUTI is not available for investing at the moment. Please verify the symbol is currently traded on NYSEMKT Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.


Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. BROOKLYN IMMUNOTHERAPEUTI's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding BROOKLYN IMMUNOTHERAPEUTI or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
BROOKLYN IMMUNOTHERAPEUTI is now traded under the symbol BTX. Please update your portfolios or report it if you believe this is an error. Report It!
New SymbolBTX
CEORam Krishnan
Average Analyst Recommendation
Analysts covering BROOKLYN IMMUNOTHERAPEUTI report their recommendations after researching BROOKLYN IMMUNOTHERAPEUTI's financial statements, talking to executives and customers, or listening in on BROOKLYN IMMUNOTHERAPEUTI's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering BROOKLYN IMMUNOTHERAPEUTI. The BROOKLYN consensus assessment is calculated by taking the average forecast from all of the analysts covering BROOKLYN IMMUNOTHERAPEUTI.
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of BROOKLYN IMMUNOTHERAPEUTI's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
BROOKLYN IMMUNOTHERAPEUTICS INC (NTN) is traded on NYSEMKT Exchange in USA and employs 22 people. The company currently falls under 'Nano-Cap' category with total capitalization of 4.02 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BROOKLYN IMMUNOTHERAPEUTI's market, we take the total number of its shares issued and multiply it by BROOKLYN IMMUNOTHERAPEUTI's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. BROOKLYN IMMUNOTHERAPEUTI runs under Communication Services sector within Broadcasting industry. The entity has 2.98 M outstanding shares of which 167.88 K shares are now shorted by investors with about 0.16 days to cover. BROOKLYN IMMUNOTHERAPEUTICS INC has about 777 K in cash with (3.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.26.
Check BROOKLYN IMMUNOTHERAPEUTI Probability Of Bankruptcy

BROOKLYN Stock Against Markets

Picking the right benchmark for BROOKLYN IMMUNOTHERAPEUTI stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in BROOKLYN IMMUNOTHERAPEUTI stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for BROOKLYN IMMUNOTHERAPEUTI is critical whether you are bullish or bearish towards BROOKLYN IMMUNOTHERAPEUTICS INC at a given time.
BROOKLYN IMMUNOTHERAPEUTICS INC cannot be verified against its exchange. Apparently, BROOKLYN IMMUNOTHERAPEUTI is not available for investing at the moment. Please verify the symbol is currently traded on NYSEMKT Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.

Try Other Stock Suggestions

Delisting Warning - NTN


  The entity BROOKLYN IMMUNOTHERAPEUTICS INC with a symbol NTN was delisted from NYSEMKT Exchange. Please use Brooklyn Immunotherapeutics with a symbol BTX from now on.


BROOKLYN IMMUNOTHERAPEUTI corporate directors refer to members of a BROOKLYN IMMUNOTHERAPEUTI board of directors. The board of directors generally takes responsibility for the BROOKLYN IMMUNOTHERAPEUTI's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of BROOKLYN IMMUNOTHERAPEUTI's board members must vote for the resolution. The BROOKLYN IMMUNOTHERAPEUTI board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Steven Mitgang - Independent DirectorProfile
Paul Yanover - Independent DirectorProfile
Richard Simtob - Independent DirectorProfile
Mary Lewis - Independent DirectorProfile


You need to understand the risk of investing before taking a position in BROOKLYN IMMUNOTHERAPEUTI. The danger of trading BROOKLYN IMMUNOTHERAPEUTICS INC is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of BROOKLYN IMMUNOTHERAPEUTI is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than BROOKLYN IMMUNOTHERAPEUTI. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile BROOKLYN IMMUNOTHERAPEUTI is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Stocks Correlation. Note that the BROOKLYN IMMUNOTHERAPEUTI information on this page should be used as a complementary analysis to other BROOKLYN IMMUNOTHERAPEUTI's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Tools for BROOKLYN Stock

When running BROOKLYN IMMUNOTHERAPEUTI price analysis, check to measure BROOKLYN IMMUNOTHERAPEUTI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BROOKLYN IMMUNOTHERAPEUTI is operating at the current time. Most of BROOKLYN IMMUNOTHERAPEUTI's value examination focuses on studying past and present price action to predict the probability of BROOKLYN IMMUNOTHERAPEUTI's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move BROOKLYN IMMUNOTHERAPEUTI's price. Additionally, you may evaluate how the addition of BROOKLYN IMMUNOTHERAPEUTI to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges